Journals / Çocuk Enfeksiyon Dergisi / 2020 / Cilt: 14 - Sayı: 2

Retrospective Evaluation of Patients with Kawasaki Disease

Kawasaki Hastalığı Tanılı Olgularımızın Geriye Yönelik Değerlendirilmesi

Pages
61–65
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is useful to keep the defined laboratory criteria in mind in order not to overlook the incomplete forms of the disease where classical KD clinical criteria are not met.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Kawasaki disease (KD) is an acute febrile disease of the childhood characterized by vasculitis.
📊
Key Findings & Data:Material and Methods: In this study, demographic characteristics, clinical and laboratory findings, treatment processes, and if any, complications of the cases diagnosed as KD during the last 5 years were retrospectively evaluated.
💡
Conclusion & Impact:It is useful to keep the defined laboratory criteria in mind in order not to overlook the incomplete forms of the disease where classical KD clinical criteria are not met.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Kawasaki disease (KD) is an acute febrile disease of the childhood characterized by vasculitis. The disease is thought to be due to the abnormal inflammatory response caused by various infectious agents in genetically predisposed individuals. It is known that the disease can be seen in all ethnic groups but it is more common in Asian populations. Although there is no recorded data on the incidence of KD in our country, it cannot be considered as a rare disease. Material and Methods: In this study, demographic characteristics, clinical and laboratory findings, treatment processes, and if any, complications of the cases diagnosed as KD during the last 5 years were retrospectively evaluated. Results: In the study, 24 patients were enrolled; 13 were males (54.2%), 11 were females (45.8%), and the median age was 25 months (range 8 to 122 months). Patients were diagnosed most frequently in spring (58.3%) and winter (29.2%). The duration of hospitalization was 11.52 ± 4.4 (range 4-23) days. The most common symptoms accompanying fever were oropharyngeal lesions (79.2-19 of patients). It was seen that 16 (66.7%) of the patients were diagnosed as complete KD and 8 (33.3%) of them were diagnosed as incomplete KD. Eighteen (75%) patients responded to intravenous immunoglobulin (IVIG) at the first dose, 6 (25%) patients had fever after 36 hours of IVIG treatment, and thus were given additional IVIG treatment and 1 (4.2%) patient did not respond to IVIG treatments and steroid was started. Eight (33.3%) of the patients were found to have cardiac involvement and 4 of them were still under antiaggregant treatment. Conclusion: Increasing awareness of incomplete forms of KD and defining incomplete KD diagnostic laboratory criteria have led to an increase in the incidence of KD in recent years. It is useful to keep the defined laboratory criteria in mind in order not to overlook the incomplete forms of the disease where classical KD clinical criteria are not met.

Özet

Giriş: Kawasaki hastalığı (KH), çocukluk çağının vaskülit ile seyreden akut ateşli bir hastalığıdır. Hastalığın, çeşitli enfeksiyon ajanlarının genetik olarak yatkın bireylerde yarattığı anormal inflamatuvar cevaba bağlı geliştiği düşünülmektedir. Hastalığın tüm etnik gruplarda görülebildiği ancak Asya kıtası kökenli popülasyonlarda daha sık görüldüğü bilinmektedir. Ülkemizde KH insidansına dair kayıtlı veri bulunmamakla birlikte nadir bir hastalık olarak nitelendirilemez. Gereç ve Yöntemler: Bu çalışmada, kliniğimizde son beş yılda KH tanısıyla takip ve tedavi edilen hastaların demografik özellikleri, klinik ve laboratuvar bulguları, tedavi süreçleri ve varsa gelişen komplikasyonlar geriye dönük olarak değerlendirildi. Bulgular: Çalışmaya dahil edilen 24 hastanın 13 (%54.2)’ü erkek, 11 (%45.8)’i kız, ortanca yaş 25 ay (aralık 8-122 ay) idi. Hastalar en sık ilkbahar (%58.3) ve kış (%29.2) mevsimlerinde tanı almıştı. Hastanede yatış süresi 11.52 ± 4.4 (aralık 4-23) gündü. Ateşe en sık olarak orofarengeal lezyonlar eşlik etmekteydi (%79.2-19 hasta). Hastaların 16 (%66.7)’sının komplet KH tanısı aldığı ve diğer 8 (%33.3) hastanın ise inkomplet KH tanısı aldığı görüldü. Hastaların 18 (%75)’inin intravenöz immünglobulin (IVIG) tedavisine ilk dozda yanıt verdiği, 6 (%25) hastanın ise IVIG tedavisinin 36. saati sonrasında ateşinin sürdüğü ve ek doz IVIG tedavisine ihtiyaç duyduğu, 1 (%4.2) hastanın ikinci doz IVIG sonrası ateşi devam ettiğinden steroid tedavisi aldığı görüldü. Hastaların 8 (%33.3)’inde kalp tutulumu saptandığı ve izlemde olan dördünün halen antiagregan tedavi almakta olduğu görüldü. Sonuç: Hastalığın inkomplet tiplerine dair farkındalığın artması ve inkomplet KH tanısı için laboratuvar kriterlerinin tanımlanmış olması, KH’nin insidansının son yıllarda artmasını sağlamıştır. Klasik KH klinik kriterlerinin karşılanmadığı inkomplet formların gözden kaçırılmaması adına literatürde yer edinen laboratuvar kriterlerinin göz önünde tutulmasında yarar vardır.

🔖

Cite This Article

CELİLOĞLU, C., TOLUNAY, O., ÖZDEMİR, U., DEMİR, H., ÇELİK, Ü. (2020). Retrospective Evaluation of Patients with Kawasaki Disease. Çocuk Enfeksiyon Dergisi, Cilt: 14 - Sayı: 2, 61–65. https://ajindex.com/articles/148769

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kliegman R, Stanton B, Schor N, St. Geme J, Behrman R (eds). Nelson Textbook of Pediatrics. 19th ed. New York: Elsevier-Health Science, 2011. [CrossRef] 2. Golshevsky D, Cheung M, Burgner D. Kawasaki disease--the importance of prompt recognition and early referral. Aust Fam Physician 2013
  2. 42(7):473-6. [CrossRef] 3. Ghimire LV, Chou FS, Mahotra NB, Sharma SP. An update on the epidemiology, length of stay, and cost of Kawasaki disease hospitalisation in the United States. Cardiol Young 2019
  3. 29(6):828-32. [CrossRef] 4. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017
  4. e927–e999. [CrossRef] 5. Okazaki K, Matsui K, Takahashi N, Miura M, Kondo M. Kawasaki disease in a preterm neonate: case report and cytokine profile. Pediatr Int 2018
  5. 60(11):1037-9. [CrossRef] 6. Advani N, Santoso LA, Sastroasmoro S. Profile of Kawasaki disease in adolescents: is it different? Acta Med Indones 2019
  6. 51(1):42-6. [CrossRef] 7. Jamieson N, Singh-Grewal D. Kawasaki disease: a clinician’s update. Int J Pediatr 2013
  7. 645391. [CrossRef] 8. Chen S, Dong Y, Kiuchi MG, Wang J, Li R, Ling Z, et al. Coronary artery complication in Kawasaki disease and the importance of early intervention: a systematic review and meta-analysis. JAMA Pediatr 2016
  8. 170(12):1156-63. [CrossRef] 9. Kawasaki T. Pediatric acute febrile mucocutaneous lymph node syndrome with characteristic desquamation of fingers and toes: my clinical observation of fifty cases. Japanese Journal of Allergy 1967
  9. 16(3):178- 222. [CrossRef] 10. Nakamura Y, Yashiro M, Uehara R, Sadakane A, Chihara I, Aoyama Y, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol 2010
  10. [CrossRef] 11. Makino N, Nakamura Y, Yashiro M, Sano T, Ae R, Kosami K, et al. Epidemiological observations of Kawasaki disease in Japan, 2013-2014. Pediatr Int 2018
  11. 60(6):581-7. [CrossRef] 12. Harnden A, Mayon-White R, Perera R, Yeates D, Goldacre M, Burgner D. Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens. Pediatr Infect Dis J 2009
  12. [CrossRef] 13. Fischer TK, Holman RC, Yorita K, Belay ED, Melbye M, Koch A. Kawasaki syndrome in Denmark. Pediatr Infect Dis J 2007
  13. 26(5):411-5. [CrossRef] 14. Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe